Next for Gilead’s Covid-fighting drug: How about an inhaled version? For more information please click here to contact Tuan Nguyen By Bizjournals.com Feed (2019-07-12 16:19:27) | April 30, 2020 Hot off solid data in two clinical trials, Gilead says it has been working on subcutaneous and even inhaled versions of its Covid-19-fighting drug remdesivir. Posted in Sacramento Business Journal